Therefore, we would argue that optineurin models that closely mimic individual ALS and FTD patient mutations are still of major relevance, but that additional environmental (infections, toxins, etc.)and genetic challenges should be carefully selected. Here, OPTN is linked to amyotrophic lateral sclerosis.